References
- Deykin D. Uremic bleeding. Kidney Int 1983; 24: 698–705
- Levin R D, Kwaan H C, Ivanovich P. Changes in platelet function during hemodialysis. J Lab Clin Med 1978; 92: 779–86
- Ylikorkala O, Huttunen K, Jarvi J, Viinikka L. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. Clin Nephrol 1982; 18: 83–7
- Knudsen F, Nielsen A H, Stoffersen E, Kornerup H J, Dyerberg J. Effect of inhibition of prostaglandin synthesis on platelet count, platelet aggregates and arterial oxygen tension during hemodialysis. Blood Purification 1983; 1: 242–6
- Stratta P, Canavese C, Mangiarotti G, et al. Heparin is unable to prevent contact activation by three different membranes. Proc Eur Dial Transplant Ass 1981; 18: 269–74
- Turney J H, Fewell M, Williams L C, Dodd N, Weston M J. Paradoxical behaviour of antithrombin III during haemodialysis and its prevention with prostacyclin. Clin Nephrol 1982; 17: 31–5
- Born G VR, Cross M J. The aggregation of blood platelets. J Physiol 1963; 168: 178–95
- Lindsay R M, Moorthy A V, Koens F, Linton A L. Platelet function in dialyzed and non-dialyzed patients with chronic renal failure. Clin Nephrol 1975; 4: 52–7
- Wu K K, Hoak J C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; ii: 924–6
- Mancini G, Carbonara A D, Heremans J F. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 1965; 2: 235–54
- Handeland G F, Abildgaard U, Aasen A O. Simplified assay for antithrombin HI activity using chromogenic peptide substrate. Scand J Haematol 1983; 31: 427–36
- Sreeharan N, Crow M J, Salter M CP, Donaldson D R, Rajah S M, Davison A M. Membrane effect on platelet function during hemodialysis: a comparison of cuprophane and polycarbonate. Artif Organs 1982; 6: 324–7
- Lindsay R M, Freisen M, Aronstam A, Andrus F, Clark W F, Linton A L. Improvement of platelet function by increased frequency of hemodialysis. Clin Nephrol 1978; 10: 67–70
- Berettini M, Bouncritiani U, Parise P, Ballatori E, Nenci G G. Polyacrilonytrile versus cuprophane membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies. Int J Artif Organs 1981; 4: 218–22
- Chenoweth D E, Cheung A K, Ward D M, Henderson L W. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers. Kidney Int 1983; 24: 770–4
- Kaplan K L, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 37: 199–202
- Lane D A, Ireland H, Knight I, Wolff S, Kyle P, Curtis J R. The significance of fibrinogen derivatives in plasma in human renal failure. Br J Haematol 1984; 56: 251–60
- van Hulsteijn H, van Es A, Bertina R, Briet E. Plasma beta-thromboglobulin and platelet factor 4 in renal failure. Thromb Res 1981; 24: 175–80
- Akizawa T, Nishiyama H, Koshikawa S. Plasma beta-thromboglobulin levels in chronic renal failure patients. Artif Organs 1981; 5: 54–8
- Buccianti G, Pogliani E, Miradoli R, et al. Reduction of plasma levels of beta-thromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregation. Clin Nephrol 1982; 18: 204–8
- Remuzzi G, Schieppati A, Mecca G. Abnormal platelet function in haemodialysed patients: current concepts. Int J Artif Organs 1979; 2: 109–12
- Remuzzi G, Beningni A, Dodesini P, et al. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?. Clin Nephrol 1982; 17: 60–3
- J0rgensen K A, Stoffersen E. Antithrombin III in uremia. Scand J Urol Nephrol 1979; 13: 299–303
- Sørensen P J, Knudsen F, Nielsen A H, Dyerberg J. Low protein C in hemodialysis patients. Blood Purification, (in press)